- Home
- LYV vs ALNY Comparison
LYV vs ALNY Comparison
Compare LYV & ALNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYV
- ALNY
- Stock Information
- Founded
- LYV 2005
- ALNY 2002
- Country
- LYV United States
- ALNY United States
- Employees
- LYV N/A
- ALNY N/A
- Industry
- LYV Services-Misc. Amusement & Recreation
- ALNY Biotechnology: Pharmaceutical Preparations
- Sector
- LYV Consumer Discretionary
- ALNY Health Care
- Exchange
- LYV Nasdaq
- ALNY Nasdaq
- Market Cap
- LYV 34.2B
- ALNY 40.4B
- IPO Year
- LYV N/A
- ALNY 2004
- Fundamental
- Price
- LYV $148.49
- ALNY $315.75
- Analyst Decision
- LYV Strong Buy
- ALNY Strong Buy
- Analyst Count
- LYV 19
- ALNY 24
- Target Price
- LYV $163.68
- ALNY $345.70
- AVG Volume (30 Days)
- LYV 2.4M
- ALNY 881.7K
- Earning Date
- LYV 07-29-2025
- ALNY 07-31-2025
- Dividend Yield
- LYV N/A
- ALNY N/A
- EPS Growth
- LYV 188.13
- ALNY N/A
- EPS
- LYV 2.97
- ALNY N/A
- Revenue
- LYV $22,738,213,000.00
- ALNY $2,348,099,000.00
- Revenue This Year
- LYV $13.23
- ALNY $32.73
- Revenue Next Year
- LYV $8.88
- ALNY $31.50
- P/E Ratio
- LYV $50.08
- ALNY N/A
- Revenue Growth
- LYV N/A
- ALNY 17.21
- 52 Week Low
- LYV $87.33
- ALNY $205.87
- 52 Week High
- LYV $157.75
- ALNY $333.70
- Technical
- Relative Strength Index (RSI)
- LYV 56.58
- ALNY 52.45
- Support Level
- LYV $142.39
- ALNY $312.96
- Resistance Level
- LYV $145.68
- ALNY $324.82
- Average True Range (ATR)
- LYV 3.19
- ALNY 9.14
- MACD
- LYV -0.59
- ALNY -2.23
- Stochastic Oscillator
- LYV 62.70
- ALNY 24.39
About LYV Live Nation Entertainment Inc.
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 45 countries, Live Nation promotes concerts globally and it owns, operates, or had exclusive booking rights to nearly 400 venues worldwide at the end of 2024, which the firm says makes it the second-largest operator of music venues globally. In 2024, Live Nation promoted nearly 55,000 events, drawing more than 150 million fans. Ticketmaster is a dominant global ticketing service, selling almost 640 million tickets in 2024.
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.